These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 18288481)

  • 1. Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer.
    Roepstorff K; Grøvdal L; Grandal M; Lerdrup M; van Deurs B
    Histochem Cell Biol; 2008 May; 129(5):563-78. PubMed ID: 18288481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocytosis and intracellular trafficking of ErbBs.
    Sorkin A; Goh LK
    Exp Cell Res; 2008 Oct; 314(17):3093-106. PubMed ID: 18793634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB Receptors and Cancer.
    Wang Z
    Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.
    Jansen SM; Sleumer LS; Damen E; Meijer IM; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2009 May; 21(5):810-8. PubMed ID: 19263517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis.
    Grandal MV; Madshus IH
    J Cell Mol Med; 2008; 12(5A):1527-34. PubMed ID: 18318691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocytosis and intracellular trafficking of ErbBs.
    Sorkin A; Goh LK
    Exp Cell Res; 2009 Feb; 315(4):683-96. PubMed ID: 19278030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor downregulation and desensitization enhance the information processing ability of signalling receptors.
    Shankaran H; Wiley HS; Resat H
    BMC Syst Biol; 2007 Nov; 1():48. PubMed ID: 17996096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.
    Frogne T; Benjaminsen RV; Sonne-Hansen K; Sorensen BS; Nexo E; Laenkholm AV; Rasmussen LM; Riese DJ; de Cremoux P; Stenvang J; Lykkesfeldt AE
    Breast Cancer Res Treat; 2009 Mar; 114(2):263-75. PubMed ID: 18409071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
    Muthuswamy SK; Gilman M; Brugge JS
    Mol Cell Biol; 1999 Oct; 19(10):6845-57. PubMed ID: 10490623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.
    Stindt S; Cebula P; Albrecht U; Keitel V; Schulte am Esch J; Knoefel WT; Bartenschlager R; Häussinger D; Bode JG
    PLoS One; 2016; 11(2):e0148711. PubMed ID: 26886748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncoprotein ErbB3 is endocytosed in the absence of added ligand in a clathrin-dependent manner.
    Sak MM; Breen K; Rønning SB; Pedersen NM; Bertelsen V; Stang E; Madshus IH
    Carcinogenesis; 2012 May; 33(5):1031-9. PubMed ID: 22436610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial regulation of epidermal growth factor receptor signaling by endocytosis.
    Ceresa BP
    Int J Mol Sci; 2012 Dec; 14(1):72-87. PubMed ID: 23344022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
    Duan L; Miura Y; Dimri M; Majumder B; Dodge IL; Reddi AL; Ghosh A; Fernandes N; Zhou P; Mullane-Robinson K; Rao N; Donoghue S; Rogers RA; Bowtell D; Naramura M; Gu H; Band V; Band H
    J Biol Chem; 2003 Aug; 278(31):28950-60. PubMed ID: 12754251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line.
    Nishimura Y; Yoshioka K; Bereczky B; Itoh K
    Mol Cancer; 2008 May; 7():42. PubMed ID: 18492291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization by different strategies of epidermal growth factor receptor and ErbB4.
    Yamamoto H; Higa-Nakamine S; Noguchi N; Maeda N; Kondo Y; Toku S; Kukita I; Sugahara K
    J Pharmacol Sci; 2014; 124(3):287-93. PubMed ID: 24553453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.
    Worthylake R; Opresko LK; Wiley HS
    J Biol Chem; 1999 Mar; 274(13):8865-74. PubMed ID: 10085130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.